Peter Attia, a renowned expert in longevity and metabolic health, highlights the benefits of GLP-1 receptor agonists in improving metabolic markers and reducing cardiovascular risks
This is the pharmacological basis for the safety discussion that follows and the reason copper balance, not peptide kinetics, is the parameter that ought to anchor any thinking about systemic exposure
Glycated hemoglobin levels decreased by 0.8 points
Highlights GLP-1 medications work by mimicking a natural gut hormone that regulates blood sugar, appetite and metabolism
105, Honda, Yasushi, et al
Originally derived from a protective compound found in gastric juice, BPC-157 has been studied for its ability to support angiogenesis (the formation of new blood vessels) and cellular processes associated with tissue maintenance and recovery support